Dexetimide
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 3-(1-benzyl-4-piperidyl)-3-phenylpiperidine-2,6-dione | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 21888-98-2 |
| ATC code | N04AA08 |
| PubChem | CID 30843 |
| ChemSpider | 28615 |
| UNII | 43477QYX3D |
| KEGG | D03711 |
| ChEMBL | CHEMBL273974 |
| Chemical data | |
| Formula | C23H26N2O2 |
| Mol. mass | 362.465 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
Dexetimide is a piperidine anticholinergic. It is a muscarinic antagonist that has been used to treat neuroleptic-induced Parkinsonism. Dexetimide was discovered at Janssen Pharmaceutica in 1968.[1][2]
[edit] References
- ^ Dom, R.; Van Lommel, R.; Baro, F. (1971). "A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent". Acta psychiatrica Scandinavica 47 (4): 399–410. PMID 4947805.
- ^ Huygens, H.; Vereecken, J. L.; Tanghe, A. (1973). "Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action". Psychiatria, neurologia, neurochirurgia 76 (4): 251–259. PMID 4581374.
|
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |

